Company Profile

Surya Pharmaceutical Limited was established in 1992, with a vision towards Empowering Life and well being, and has rapidly emerged as the premier integrated pharmaceutical company in India. Its business focuses on the manufacture and marketing of pharmaceutical products and services to clients across the globe, and its product & services portfolio includes a range of Active Pharmaceutical Ingredients (APIs), Intermediates, Branded Ethical Formulations, Phyto Pharmaceuticals and Contract Research and Manufacturing Services.

The company is one of the largest manufacturers and exporters of Mint / Menthol derivatives and also manages state of the art research & development centres that offer the highest quality of Contract Research and Manufacturing Services. Over the years, Surya Pharmaceutical Limited has established a global footprint in fulfilling the requirements of clients across 90 countries.

At Surya Pharmaceutical, we believe that if we take care of the present, we inspire a better future. It is this vision towards a disease-free world, a sustainable natural environment and a healthy global population, that supports our commitment to ensure the highest quality of products and services towards offering unparalled care to our clients, and to the larger community.

Surya Pharmaceutical Limited is the flagship company of Surya Corp which has business interests in Healthcare, Education, Infrastructure and Communications. The company is an ISO 9001-2008, WHO GMP certified organization with six state-of-the-art manufacturing units positioned in multiple locations across the northern region in India. With a focus on innovation and quality, the company has demonstrated unparalled growth and is listed on both the Bombay Stock Exchange and the National Stock Exchange.

The company currently supports a personnel base of more than 2500 employees in locations across India and has expanded its network of overseas offices to China, Singapore & USA and set up a Research and Development Centre at San Diego, USA to further strengthen its position as one of the leading exporters of pharmaceutical products.